High Frequency of Specific Polysaccharide Antibody Deficiency in Adults With Unexplained, Recurrent and/or Severe Infections With Encapsulated Bacteria
Clinical Infectious Diseases · 2023
DOI: 10.1093/cid/ciac842 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Sarah Stabler und 33 weiteren Autor:innen. Beteiligte Einrichtung: Département de médecine interne et immunologie clinique, CHU Lille, Lille, France. Hauptthemen laut MEDLINE: Immunologic Deficiency Syndromes, Bacterial Infections, Primary Immunodeficiency Diseases, Pneumococcal Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: CEREDIH, Association IRIS, CSL Behring, LFB, Octapharma, Vitalaire, and The Binding Site.
Abstract (Originalsprache)
Background
Primary immunodeficiencies (PIDs) in adults are mainly revealed by recurrent and/or severe bacterial infections. The objective of this study was to evaluate a systematic research strategy of PIDs in adults with unexplained bacterial infections, with a special focus on specific polysaccharide antibody deficiency (SPAD).
Methods
In this prospective multicenter study, inclusion criteria were recurrent benign upper and lower respiratory tract infections (RTIs) for at least two years (group 1), at least one upper or lower RTI requiring hospitalization (group 2), and/or at least one invasive infection documented with encapsulated bacteria (group 3). Main exclusion criteria were all local and general conditions that could explain infections. If no PID diagnosis was made, response to polysaccharide antigens was assessed using a pneumococcal polysaccharide vaccine.
Results
From March 2015 to March 2020, 118 patients were included (37 males, median age of 41 years): 73, 17, and 28 in groups 1, 2, and 3, respectively. Forty-seven PIDs were diagnosed, giving an estimated frequency of 39.8% (95% confidence interval [CI] [30.4, 48.8]). SPAD was the most frequent diagnosis by far (n = 37/47, 78.7%), and was made in 23, 5, and 9 patients from groups 1 to 3, respectively. All SPAD patients received conjugate vaccines and, according to their infectious history, were on surveillance or treated with preventive antibiotics (n = 6) and/or with immunoglobulins replacement therapy (n = 10), the latter being dramatically efficient in all cases.
Conclusions
Considering its high prevalence among adults with unexplained recurrent and/or severe bacterial infections, SPAD should be screened in those patients. Clinical Trials Registration NCT02972281.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de médecine interne et immunologie clinique, CHU Lille, Lille, France.
- Centre de Référence des Maladies Auto-immunes et Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), Lille, France.
- Département de maladies infectieuses et tropicales, CHU Lille, Lille, France.
- Université Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, Lille, France.
- Département de pneumologie, Hôpital privé La Louvière, Lille, France.
- Département de pneumologie, Clinique Tessier, Valenciennes, France.
Förderung
- CEREDIH, Association IRIS, CSL Behring, LFB, Octapharma, Vitalaire, and The Binding Site
Zitieren
APA
Stabler, S., Lamblin, C., Gaillard, S., Just, N., Mihailescu, M., Viget, N., Sy Ndiaye, T., Dzeing Ella, A., Brunin, G., Weyrich, P., Prevotat, A., Chenivesse, C., Le Rouzic, O., Mortuaire, G., Vuotto, F., Faure, K., Leurs, A., Wallet, F., Loiez, C., …, & DIPANOR network (2023). High Frequency of Specific Polysaccharide Antibody Deficiency in Adults With Unexplained, Recurrent and/or Severe Infections With Encapsulated Bacteria. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac842
Vancouver
Stabler S, Lamblin C, Gaillard S, Just N, Mihailescu M, Viget N, et al. High Frequency of Specific Polysaccharide Antibody Deficiency in Adults With Unexplained, Recurrent and/or Severe Infections With Encapsulated Bacteria. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac842
BibTeX
@article{Stabler2023,
author = {Stabler, Sarah and Lamblin, Catherine and Gaillard, Sacha and Just, Nicolas and Mihailescu, Mirela and Viget, Nathalie and Sy Ndiaye, Thierno and Dzeing Ella, Arnaud and Brunin, Guillaume and Weyrich, Pierre and Prevotat, Anne and Chenivesse, Cécile and Le Rouzic, Olivier and Mortuaire, Geoffrey and Vuotto, Fanny and Faure, Karine and Leurs, Amélie and Wallet, Frédéric and Loiez, Caroline and Titecat, Marie and Le Guern, Rémi and Hachulla, Eric and Sanges, Sébastien and Etienne, Nicolas and Terriou, Louis and Launay, David and Lopez, Benjamin and Bahuaud, Mathilde and Batteux, Frédéric and Dubucquoi, Sylvain and Gesquière-Lasselin, Cyrielle and Labalette, Myriam and Lefèvre, Guillaume and DIPANOR network, DIPANOR network},
title = {High Frequency of Specific Polysaccharide Antibody Deficiency in Adults With Unexplained, Recurrent and/or Severe Infections With Encapsulated Bacteria},
journal = {Clinical Infectious Diseases},
year = {2023},
doi = {10.1093/cid/ciac842}
}
EUVIMED